2017 Formulary Strategy: Helping Contain Prescription Drug Costs


At CVS Health, we are acting vigilantly to help our clients contain their costs while supporting their members with affordable prescription drugs benefits. A key to containing cost is effective formulary management. This is essential at a time when escalating drug prices as well as the introduction of new costly therapies are creating significant challenges to the affordability of health care. Our solutions include rapid responses to the quickly evolving market.

Our 2017 formulary management strategy continues to address emerging cost drivers with new, market-leading enhancements:

  • Embracing the Future with Biosimilars and Follow-on Biologics

  • Creating Additional Client Value with Indication-Based Formulary

  • Tackling Hyperinflationary Drugs to Reduce Their Cost Impact

We are also taking steps to address “limited source generics” which are products with limited generic manufacturers resulting in significant cost in the market. These products will be evaluated and if appropriate, be excluded during the year.

Learn more in our recent 2017 formulary strategy communication.

Featured News Coverage

CVS Health Takes “An Audacious Step” With 2017 Drug Formularies
By Johanna Bennett, Barron’s, August 2, 2016

CVS Cuts Coverage of Dozens of Drugs in Exclusion Expansion
By Robert Langreth, Bloomberg, August 2, 2016

Biologic Drugmakers Use Patents, Suits to Thwart Generic Competition
By Jayne O'Donnell, USA TODAY, August 4, 2016